Jump to navigation
ジャンル
TOP STORIES
REGULATORY
BUSINESS
ORGANIZATION
ACADEMIA
OTHERS
COMMENTARY
COLUMN
TRENDS
FEATURE
INTERVIEW
LEXICON
HOME
> FEATURE
FEATURE
FY2018 Earnings Roundup
Upside in Decelerating Gx Arena
My Viewpoint on CEA
HTA Debates in 2018-2019
Takeda’s £46 Billion Shire Buyout
I/O in Lung Cancer
Special Interview on Long-Listed Products and Generic Drugs
ページ
« 先頭
‹ Prev
1
2
